Merck & Co., Inc. (MRK)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
73.13+0.96 (+1.33%)
At close: 4:02PM EST
| Previous close | 72.17 |
| Open | 72.51 |
| Bid | 0.00 x 1300 |
| Ask | 0.00 x 1200 |
| Day's range | 72.01 - 73.41 |
| 52-week range | 65.25 - 87.80 |
| Volume | 11,680,507 |
| Avg. volume | 10,429,216 |
| Market cap | 185.042B |
| Beta (5Y monthly) | 0.43 |
| PE ratio (TTM) | 26.31 |
| EPS (TTM) | 2.78 |
| Earnings date | 29 Apr 2021 |
| Forward dividend & yield | 2.60 (3.56%) |
| Ex-dividend date | 12 Mar 2021 |
| 1y target est | 96.33 |
- Simply Wall St.
Merck & Co., Inc. (NYSE:MRK) Goes Ex-Dividend Soon
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...
- Zacks
Why Is Merck (MRK) Down 3.8% Since Last Earnings Report?
Merck (MRK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Business Wire
Ridgeback Biotherapeutics and Merck Announce Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Therapeutic Molnupiravir
Ridgeback Biotherapeutics and Merck Announce Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Therapeutic Molnupiravir
© 2021 Verizon Media. All rights reserved.
